Naksha Pharmaceuticals Private Limited
About Naksha Pharmaceuticals Private Limited
Data last updated:
Naksha Pharmaceuticals Private Limited is a private limited company based in Jogeshwari East, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 15 April 2022.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51220MH2022PTC380591. Its GSTIN is 27AAICN1936B1ZO (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Kishori Vaibhav Kanodia and Vaibhav Mahendra Kanodia.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Jogeshwari East, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹40.24 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹37.9 Lakh (net margin 0.9%) and EBITDA of ₹1.02 Cr (EBITDA margin 2.5%).
As per MCA filings, the company has open charges of ₹8 Cr on record.
Company details
Contact details
Naksha Pharmaceuticals Private Limited's registered office is in Jogeshwari East, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address1211 12th Floor Hubtown Viva Shankarwadi, W.E Highway Mogara Village, Jogeshwari East, Maharashtra, India – 400060
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Naksha Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Naksha Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Naksha Pharmaceuticals Private Limited, buy the company report.
Financials of Naksha Pharmaceuticals Private Limited
FY 2025 filings availableNaksha Pharmaceuticals Private Limited reported revenue of ₹40.24 Cr (up 154% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 154% in the latest year. EBITDA rose 81% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹1.02 Cr | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹37.9 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 2.5% | ||
| Net Profit Margin | 0.9% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Naksha Pharmaceuticals Private Limited, buy the company report.
Board of directors of Naksha Pharmaceuticals Private Limited
Naksha Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kishori Vaibhav Kanodia | Director | 15 Apr 2022 | 4 Years 6 Months | Current |
| Vaibhav Mahendra Kanodia | Director | 15 Apr 2022 | 4 Years 6 Months | Current |
| Kapilkumar Rajendraprasad Sharma Also directs: Deep Art Productions LLP, Navnature Industries Private Limited, Greenstay Resorts Private Limited and 1 more | Additional Director | 01 Dec 2024 | 1 Years 11 Months | Current |
Peer comparison
Naksha Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mil Medical Dental Systems Private Limited | ₹40.24 Cr (FY 2025) | -1.0% | Nagpur, Maharashtra, India | |||
| Naksha Pharmaceuticals Private Limitedthis company | ₹40.24 Cr (FY 2025) | ₹37.9 Lakh | 0.9% | 154.0% | Jogeshwari East, Maharashtra, India | |
| Ansh Therapeutics Private Limited | ₹40 Cr (FY 2025) | 1.0% | New Delhi, Delhi, India | |||
| Shri Navdeep Healthcare Private Limited | ₹39.74 Cr (FY 2024) | 1.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Naksha Pharmaceuticals Private Limited, buy the company report.
Auditor
Naksha Pharmaceuticals Private Limited is audited by SARAF SARAF AND ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SARAF SARAF AND ASSOCIATES | FY 2023 | 124333W |
Shareholding
The shareholding of Naksha Pharmaceuticals Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Naksha Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 May 2023 | 100761761 | Indian Bank | ₹8 Cr | Open |
To see the full charge records of Naksha Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Naksha Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Naksha Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Naksha Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 07, 2024.
GST
Naksha Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICN1936B1ZO | Maharashtra | Active | 02 May 2022 |
To see the full GST registrations and return filing status of Naksha Pharmaceuticals Private Limited, buy the company report.
Recent activity
Naksha Pharmaceuticals Private Limited has 3 board changes on record since 2022: 3 appointments. The latest: Kapilkumar Rajendraprasad Sharma was appointed as Additional Director on 01 Dec 2024.
Frequently asked questions
Naksha Pharmaceuticals is an active private limited company based in Jogeshwari East, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 15 April 2022 (4+ years old) and is registered under CIN U51220MH2022PTC380591.
Naksha Pharmaceuticals has 3 current directors:
- Kishori Vaibhav Kanodia - Director
- Vaibhav Mahendra Kanodia - Director
- Kapilkumar Rajendraprasad Sharma - Additional Director
The latest financial statements of Naksha Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Naksha Pharmaceuticals is 27AAICN1936B1ZO, registered in Maharashtra.
The CIN (Corporate Identification Number) of Naksha Pharmaceuticals is U51220MH2022PTC380591. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Naksha Pharmaceuticals was incorporated on 15 April 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Naksha Pharmaceuticals by revenue are Mil Medical Dental Systems Private Limited, Ansh Therapeutics Private Limited, Shri Navdeep Healthcare Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Kapilkumar Rajendraprasad Sharma was appointed as Additional Director on 01 Dec 2024. Kishori Vaibhav Kanodia was appointed as Director on 15 Apr 2022. Vaibhav Mahendra Kanodia was appointed as Director on 15 Apr 2022.
The registered office of Naksha Pharmaceuticals is at 1211 12th Floor Hubtown Viva Shankarwadi, W.E Highway Mogara Village, Jogeshwari East, Maharashtra, India – 400060.
Naksha Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Naksha Pharmaceuticals has open charges of ₹8 Cr and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
